152 related articles for article (PubMed ID: 11115510)
1. Roles of NF-kappaB and 26 S proteasome in apoptotic cell death induced by topoisomerase I and II poisons in human nonsmall cell lung carcinoma.
Tabata M; Tabata R; Grabowski DR; Bukowski RM; Ganapathi MK; Ganapathi R
J Biol Chem; 2001 Mar; 276(11):8029-36. PubMed ID: 11115510
[TBL] [Abstract][Full Text] [Related]
2. Proteasome inhibition with bortezomib enhances activity of topoisomerase I-targeting drugs by NF-kappaB-independent mechanisms.
Takigawa N; Vaziri SA; Grabowski DR; Chikamori K; Rybicki LR; Bukowski RM; Ganapathi MK; Ganapathi R; Mekhail T
Anticancer Res; 2006; 26(3A):1869-76. PubMed ID: 16827119
[TBL] [Abstract][Full Text] [Related]
3. NF-kappa B activation in topoisomerase I inhibitor-induced apoptotic cell death in human non-small cell lung cancer.
Tabata M; Ganapathi R
Ann N Y Acad Sci; 2000; 922():343-4. PubMed ID: 11193918
[No Abstract] [Full Text] [Related]
4. Inhibition of NF-kappaB and proteasome activity in tumors: can we improve the therapeutic potential of topoisomerase I and topoisomerase II poisons.
Ganapathi R; Vaziri SA; Tabata M; Takigawa N; Grabowski DR; Bukowski RM; Ganapathi MK
Curr Pharm Des; 2002; 8(22):1945-58. PubMed ID: 12171521
[TBL] [Abstract][Full Text] [Related]
5. Prevention of etoposide-induced apoptosis by proteasome inhibitors in a human leukemic cell line but not in fresh acute leukemia blasts. A differential role of NF-kappab activation.
Watanabe K; Kubota M; Hamahata K; Lin Y; Usami I
Biochem Pharmacol; 2000 Sep; 60(6):823-30. PubMed ID: 10930537
[TBL] [Abstract][Full Text] [Related]
6. Topoisomerase inhibitor-induced apoptosis accompanied by down-regulation of Bcl-2 in human lung cancer cells.
Oizumi S; Isobe H; Ogura S; Ishida T; Yamazaki K; Nishimura M; Kawakami Y; Dosaka-Akita H
Anticancer Res; 2002; 22(6C):4029-37. PubMed ID: 12553028
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin enhances irinotecan-induced apoptosis in human non-small cell lung cancer cells by inhibition of proteasome activity.
Park IH; Kim JY; Choi JY; Han JY
Invest New Drugs; 2011 Oct; 29(5):883-90. PubMed ID: 20467885
[TBL] [Abstract][Full Text] [Related]
8. Activation of nuclear factor kappaB through the IKK complex by the topoisomerase poisons SN38 and doxorubicin: a brake to apoptosis in HeLa human carcinoma cells.
Bottero V; Busuttil V; Loubat A; Magné N; Fischel JL; Milano G; Peyron JF
Cancer Res; 2001 Nov; 61(21):7785-91. PubMed ID: 11691793
[TBL] [Abstract][Full Text] [Related]
9. The ATM protein is required for sustained activation of NF-kappaB following DNA damage.
Piret B; Schoonbroodt S; Piette J
Oncogene; 1999 Apr; 18(13):2261-71. PubMed ID: 10327072
[TBL] [Abstract][Full Text] [Related]
10. S phase dependence and involvement of NF-kappaB activating kinase to NF-kappaB activation by camptothecin.
Habraken Y; Piret B; Piette J
Biochem Pharmacol; 2001 Sep; 62(5):603-16. PubMed ID: 11585057
[TBL] [Abstract][Full Text] [Related]
11. Caspase cleavage product lacking amino-terminus of IkappaBalpha sensitizes resistant cells to TNF-alpha and TRAIL-induced apoptosis.
Kim KW; Kim BJ; Chung CW; Jo DG; Kim IK; Song YH; Kwon YK; Woo HN; Jung YK
J Cell Biochem; 2002; 85(2):334-45. PubMed ID: 11948689
[TBL] [Abstract][Full Text] [Related]
12. NF-kappaB activation by camptothecin. A linkage between nuclear DNA damage and cytoplasmic signaling events.
Huang TT; Wuerzberger-Davis SM; Seufzer BJ; Shumway SD; Kurama T; Boothman DA; Miyamoto S
J Biol Chem; 2000 Mar; 275(13):9501-9. PubMed ID: 10734098
[TBL] [Abstract][Full Text] [Related]
13. Phytochemical naphtho[1,2-b] furan-4,5‑dione induced topoisomerase II-mediated DNA damage response in human non-small-cell lung cancer.
Chien CM; Yang JC; Wu PH; Wu CY; Chen GY; Wu YC; Chou CK; Tseng CH; Chen YL; Wang LF; Chiu CC
Phytomedicine; 2019 Feb; 54():109-119. PubMed ID: 30668360
[TBL] [Abstract][Full Text] [Related]
14. The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors.
Dubrez L; Goldwasser F; Genne P; Pommier Y; Solary E
Leukemia; 1995 Jun; 9(6):1013-24. PubMed ID: 7596166
[TBL] [Abstract][Full Text] [Related]
15. Proteasome inhibitors potentiate leukemic cell apoptosis induced by the cyclin-dependent kinase inhibitor flavopiridol through a SAPK/JNK- and NF-kappaB-dependent process.
Dai Y; Rahmani M; Grant S
Oncogene; 2003 Oct; 22(46):7108-22. PubMed ID: 14562039
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of NF-kappa B with proteasome inhibitors enhances apoptosis in human lung adenocarcinoma cells in vitro.
Milligan SA; Nopajaroonsri C
Anticancer Res; 2001; 21(1A):39-44. PubMed ID: 11299767
[TBL] [Abstract][Full Text] [Related]
17. Cellular and molecular responses to topoisomerase I poisons. Exploiting synergy for improved radiotherapy.
Miyamoto S; Huang TT; Wuerzberger-Davis S; Bornmann WG; Pink JJ; Tagliarino C; Kinsella TJ; Boothman DA
Ann N Y Acad Sci; 2000; 922():274-92. PubMed ID: 11193903
[TBL] [Abstract][Full Text] [Related]
18. QS-ZYX-1-61 induces apoptosis through topoisomerase II in human non-small-cell lung cancer A549 cells.
Chen MC; Pan SL; Shi Q; Xiao Z; Lee KH; Li TK; Teng CM
Cancer Sci; 2012 Jan; 103(1):80-7. PubMed ID: 21920000
[TBL] [Abstract][Full Text] [Related]
19. The apoptotic effects and synergistic interaction of sodium butyrate and MG132 in human retinoblastoma Y79 cells.
Giuliano M; Lauricella M; Calvaruso G; Carabillò M; Emanuele S; Vento R; Tesoriere G
Cancer Res; 1999 Nov; 59(21):5586-95. PubMed ID: 10554039
[TBL] [Abstract][Full Text] [Related]
20. ERK1/2 signaling plays an important role in topoisomerase II poison-induced G2/M checkpoint activation.
Kolb RH; Greer PM; Cao PT; Cowan KH; Yan Y
PLoS One; 2012; 7(11):e50281. PubMed ID: 23166842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
